tirzepatide fda approved Approves (Zepbound) as the First Medication for Obstructive Sleep Apnea Compounded Tirzepatide for Weight Loss

What to Know About the BALANCE Model for GLP-1s in Medicare and Medicaid and the Medicare GLP-1 Bridge Editorial Note This brief was updated on May 11, 2026 to reflect changes in the Trump administrations plans for implementation of the BALANCE Model in Medicare and an extension of the Medicare GLP-1 Bridge program through 2027

Eli Lilly has been at the forefront of this anti-inflammatory mechanism of GLP-1 meds

Selenium and asthma

Understanding tirzepatide dose-response for informed conversion decisions Knowing the conversion math is only half the picture

They apply exclusively to regulated clinical trial or research pharmacy settings